Nu Holdings Ltd. (NU) ended the recent trading session at $12.83, demonstrating a -1.53% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 0.33% for the day. Meanwhile, the Dow lost 0.63%, and the Nasdaq, a tech-heavy index, lost 0.22%. The company's shares have seen an increase of 8.58% over the last month, surpassing the Finance sector's gain of 3.2% and the S&P 500's gain of 4.07%.Analysts and investors alike will be keeping a close eye on the ...

Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew (SNN) and EssilorLuxottica Unsponsored ADR (ESLOY) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with str ...

Company Performance - BlackRock (BLK) closed at $1,104.05, marking a +1.41% move from the prior day, outperforming the S&P 500's daily gain of 0.28% [1] - The stock has risen by 9.61% in the past month, leading the Finance sector's gain of 2.79% and the S&P 500's gain of 4.37% [1] Earnings Estimates - BlackRock is set to release its earnings on July 15, 2025, with projected EPS of $10.77, indicating a 3.96% increase year-over-year [2] - Revenue is expected to be $5.38 billion, up 12.02% from the prior-year quarter [2] - For the full year, analysts expect earnings of $45.73 per share and revenue of $22.72 billion, reflecting changes of +4.86% and +11.33% respectively from last year [3] Analyst Sentiment - Recent modifications to analyst estimates for BlackRock indicate changing near-term business trends, with positive revisions reflecting analyst optimism [4] - The Zacks Rank system, which assesses these estimate changes, currently ranks BlackRock at 2 (Buy) [6] Valuation Metrics - BlackRock has a Forward P/E ratio of 23.81, compared to the industry average of 12.15, suggesting it is trading at a premium [7] - The company has a PEG ratio of 3.25, while the average PEG ratio for the Financial - Investment Management industry is 1.42 [8] Industry Context - The Financial - Investment Management industry is part of the Finance sector and holds a Zacks Industry Rank of 62, placing it in the top 26% of all industries [9]

Company Performance - Nutanix (NTNX) closed at $73.61, down 3.84% from the previous trading session, underperforming the S&P 500's gain of 0.28% [1] - Over the past month, Nutanix shares gained 3.35%, lagging behind the Computer and Technology sector's gain of 6.2% and the S&P 500's gain of 4.37% [1] Earnings Expectations - The upcoming earnings report is expected to show an EPS of $0.31, representing a 14.81% increase year-over-year [2] - Revenue is forecasted to be $642.3 million, indicating a 17.22% growth compared to the same quarter last year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $1.72 per share and revenue at $2.53 billion, reflecting increases of 31.3% and 17.58% respectively from the previous year [3] - Recent analyst estimate revisions are crucial as they indicate near-term business trends and reflect analyst optimism [3] Analyst Ratings and Valuation - The Zacks Rank system currently rates Nutanix at 3 (Hold), with a recent downward shift of 2.23% in the consensus EPS estimate [5] - Nutanix has a Forward P/E ratio of 44.41, significantly higher than the industry average of 20.02, indicating a premium valuation [6] - The PEG ratio for Nutanix stands at 2.19, compared to the industry average of 2.09 [6] Industry Context - The Computers - IT Services industry, part of the Computer and Technology sector, holds a Zacks Industry Rank of 87, placing it in the top 36% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Performance - Target's stock closed at $104.74, reflecting a +2.26% change from the previous day's closing price, outperforming the S&P 500's daily gain of 0.28% [1] - The stock has increased by 4.4% over the past month, leading the Retail-Wholesale sector's gain of 0.87% and the S&P 500's gain of 4.37% [1] Earnings Forecast - Target is expected to report an EPS of $2.08, indicating a 19.07% decrease from the same quarter last year, with a projected quarterly revenue of $24.88 billion, down 2.26% year-over-year [2] - Full-year estimates predict earnings of $7.55 per share and revenue of $104.65 billion, representing year-over-year declines of -14.79% and -1.79%, respectively [3] Analyst Estimates and Rankings - Recent changes in analyst estimates are crucial for investors, as they reflect the evolving business landscape, with positive revisions indicating confidence in performance [3][4] - Target currently holds a Zacks Rank of 3 (Hold), with the Zacks Consensus EPS estimate having increased by 0.57% over the last 30 days [5] Valuation Metrics - Target's Forward P/E ratio stands at 13.57, which is a discount compared to the industry average of 20.89 [6] - The PEG ratio for Target is 2.93, compared to the Retail - Discount Stores industry's average PEG ratio of 2.76 [6] Industry Context - The Retail - Discount Stores industry is part of the Retail-Wholesale sector and has a Zacks Industry Rank of 90, placing it in the top 37% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Performance - Intel's stock closed at $23.82, with a daily increase of +1.62%, outperforming the S&P 500's gain of 0.28% [1] - Over the past month, Intel's stock has risen by 13.35%, surpassing the Computer and Technology sector's gain of 6.2% and the S&P 500's gain of 4.37% [1] Upcoming Earnings - Intel's earnings report is expected on July 24, 2025, with a forecasted EPS of $0.01, reflecting a 50% decrease from the same quarter last year [2] - Revenue is projected to be $11.87 billion, indicating a 7.53% decline compared to the year-ago quarter [2] Full Year Projections - For the full year, earnings are estimated at $0.28 per share, representing a +315.38% change from the prior year, while revenue is projected at $50.8 billion, showing a -4.33% change [3] Analyst Estimates - Recent modifications to analyst estimates for Intel indicate near-term business trends, with upward revisions suggesting analysts' positivity towards the company's operations [4] - The Zacks Rank system, which reflects these estimate changes, currently rates Intel at 4 (Sell), with a recent downward shift of 3.8% in the EPS estimate [6] Valuation Metrics - Intel's Forward P/E ratio stands at 84.09, significantly higher than the industry average of 39 [7] - The company has a PEG ratio of 8.02, compared to the Semiconductor - General industry's average PEG ratio of 2.72 [7] Industry Context - The Semiconductor - General industry is part of the Computer and Technology sector, holding a Zacks Industry Rank of 62, placing it in the top 26% of over 250 industries [8]

Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Astrana Health, Inc. (ASTH) or Chemed (CHE) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets compani ...

Adma Biologics (ADMA) ended the recent trading session at $18.34, demonstrating a +2.98% change from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.61%. On the other hand, the Dow registered a gain of 0.49%, and the technology-centric Nasdaq increased by 0.95%. Coming into today, shares of the infectious disease drug developer had lost 14.62% in the past month. In that same time, the Medical sector lost 0.67%, while the S&P 500 gained 3.85%. Market participants will be c ...

Company Performance - Royal Caribbean (RCL) closed at $333.57, with a +1.02% increase from the previous day, outperforming the S&P 500's gain of 0.61% [1] - The stock has risen by 22.43% over the past month, significantly exceeding the Consumer Discretionary sector's gain of 5.12% and the S&P 500's gain of 3.85% [1] Upcoming Financial Results - The projected earnings per share (EPS) for Royal Caribbean is $4.05, reflecting a 26.17% increase from the same quarter last year [2] - Revenue is expected to reach $4.54 billion, up 10.58% from the prior-year quarter [2] Fiscal Year Estimates - For the entire fiscal year, earnings are estimated at $15.43 per share and revenue at $18.05 billion, indicating increases of +30.76% and +9.48% respectively from the previous year [3] - Recent analyst estimate changes suggest a favorable outlook on the company's business health and profitability [3] Valuation Metrics - Royal Caribbean has a Forward P/E ratio of 21.4, which is a discount compared to the industry average Forward P/E of 21.76 [6] - The company holds a PEG ratio of 0.98, compared to the industry average PEG ratio of 1.99 [6] Industry Context - The Leisure and Recreation Services industry, part of the Consumer Discretionary sector, has a Zacks Industry Rank of 68, placing it in the top 28% of over 250 industries [7] - The top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Carvana (CVNA) closed at $345.92 in the latest trading session, marking a -3.19% move from the prior day. This move lagged the S&P 500's daily loss of 0.07%. Elsewhere, the Dow lost 0.37%, while the tech-heavy Nasdaq added 0.03%. The company's shares have seen an increase of 5.12% over the last month, surpassing the Retail-Wholesale sector's gain of 1.87% and the S&P 500's gain of 3.94%.The investment community will be paying close attention to the earnings performance of Carvana in its upcoming release. Th ...